These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21554078)

  • 1. Binding-interaction prediction of RNA-binding ligands.
    Tuccinardi T
    Future Med Chem; 2011 Apr; 3(6):723-33. PubMed ID: 21554078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy assessment of protein-based docking programs against RNA targets.
    Li Y; Shen J; Sun X; Li W; Liu G; Tang Y
    J Chem Inf Model; 2010 Jun; 50(6):1134-46. PubMed ID: 20481574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular recognition of RNA: challenges for modelling interactions and plasticity.
    Fulle S; Gohlke H
    J Mol Recognit; 2010; 23(2):220-31. PubMed ID: 19941322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico screening of quadruplex-binding ligands.
    Ma DL; Ma VP; Chan DS; Leung KH; Zhong HJ; Leung CH
    Methods; 2012 May; 57(1):106-14. PubMed ID: 22391485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking and scoring in virtual screening for drug discovery: methods and applications.
    Kitchen DB; Decornez H; Furr JR; Bajorath J
    Nat Rev Drug Discov; 2004 Nov; 3(11):935-49. PubMed ID: 15520816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved lead-finding for kinase targets using high-throughput docking.
    McInnes C
    Curr Opin Drug Discov Devel; 2006 May; 9(3):339-47. PubMed ID: 16729730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques.
    Good AC; Cheney DL
    J Mol Graph Model; 2003 Sep; 22(1):23-30. PubMed ID: 12798388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating structure-based and ligand-based approaches for computational drug design.
    Wilson GL; Lill MA
    Future Med Chem; 2011 Apr; 3(6):735-50. PubMed ID: 21554079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible computational docking studies of new aminoglycosides targeting RNA 16S bacterial ribosome site.
    Barbault F; Ren B; Rebehmed J; Teixeira C; Luo Y; Smila-Castro O; Maurel F; Fan B; Zhang L; Zhang L
    Eur J Med Chem; 2008 Aug; 43(8):1648-56. PubMed ID: 18096272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the design of RNA-binding small molecules.
    Aboul-ela F
    Future Med Chem; 2010 Jan; 2(1):93-119. PubMed ID: 21426048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximum common binding modes (MCBM): consensus docking scoring using multiple ligand information and interaction fingerprints.
    Renner S; Derksen S; Radestock S; Mörchen F
    J Chem Inf Model; 2008 Feb; 48(2):319-32. PubMed ID: 18211051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening.
    Rastelli G; Degliesposti G; Del Rio A; Sgobba M
    Chem Biol Drug Des; 2009 Mar; 73(3):283-6. PubMed ID: 19207463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of automated docking programs for docking and database screening against RNA drug targets.
    Detering C; Varani G
    J Med Chem; 2004 Aug; 47(17):4188-201. PubMed ID: 15293991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacophore docking algorithm and its application to the cross-docking of 18 HIV-NNRTI's in their binding pockets.
    Daeyaert F; de Jonge M; Heeres J; Koymans L; Lewi P; Vinkers MH; Janssen PA
    Proteins; 2004 Feb; 54(3):526-33. PubMed ID: 14748000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the FACTS solvation model for protein-ligand docking calculations. Application to EADock.
    Zoete V; Grosdidier A; Cuendet M; Michielin O
    J Mol Recognit; 2010; 23(5):457-61. PubMed ID: 20101644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive docking study on the selectivity of binding of aromatic compounds to proteins.
    Hetényi C; Maran U; Karelson M
    J Chem Inf Comput Sci; 2003; 43(5):1576-83. PubMed ID: 14502492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of ligands by a combination of computational and NMR-based screening: RNA as an example target.
    Mayer M; James TL
    Methods Enzymol; 2005; 394():571-87. PubMed ID: 15808238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based approaches to drug design and virtual screening.
    Waszkowycz B
    Curr Opin Drug Discov Devel; 2002 May; 5(3):407-13. PubMed ID: 12058616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.